{"id":"micro-particle-curcumin","safety":{"commonSideEffects":[{"rate":null,"effect":"Gastrointestinal upset"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Abdominal discomfort"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Curcumin is the active compound from turmeric that exerts pleiotropic effects including inhibition of NF-κB signaling, reduction of pro-inflammatory cytokines, and antioxidant activity. The micro-particle formulation aims to overcome curcumin's poor oral bioavailability and rapid metabolism, allowing greater systemic exposure and tissue penetration for therapeutic benefit.","oneSentence":"Micro-particle curcumin is a formulation of the natural polyphenol curcumin designed to improve bioavailability and enhance anti-inflammatory and antioxidant effects in the body.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:21:21.151Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Inflammatory bowel disease"},{"name":"Cancer-related inflammation"}]},"trialDetails":[{"nctId":"NCT02369549","phase":"PHASE3","title":"Micro-Particle Curcumin for the Treatment of Chronic Kidney Disease","status":"COMPLETED","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2015-09","conditions":"Chronic Kidney Disease","enrollment":518}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Theracumin-Pro 300"],"phase":"phase_3","status":"active","brandName":"Micro-particle Curcumin","genericName":"Micro-particle Curcumin","companyName":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","companyId":"london-health-sciences-centre-research-institute-or-lawson-research-institute-of","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Micro-particle Curcumin is a small molecule intervention being studied for the treatment of Chronic Kidney Disease in a clinical trial. Curcumin, also known as CI 75300, is a compound being investigated in this trial.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}